首頁 › 胰臟癌 › 加州 › Los Angeles
Los Angeles, CA 的 胰臟癌 臨床試驗
35 項針對 胰臟癌 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
招募中3 期
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US027, Los Angeles
- Investigative Site US036, Los Angeles
- Investigative Site US048, Los Angeles
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
招募中3 期
- Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Hematology/Oncology- Santa Monica, Los Angeles
CREO - Microwave Ablation Feasibility Study
招募中
- Cedars Sinai, Los Angeles
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
招募中觀察性研究
- Children's Hospital Los Angeles, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- USC/Norris Comprehensive Cancer Center, Los Angeles
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中觀察性研究
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
招募中2 期
- START- Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
招募中
- Cedars-Sinai, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
招募中1 期
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
招募中1 期
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- The Angeles Clinic and Research Institute, Los Angeles
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
招募中1/2 期
- California Research Institute, Los Angeles
Pancreatic Cancer Early Detection Consortium
招募中觀察性研究歡迎健康志工
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Health, Los Angeles
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
招募中2 期
- Cedars-Sinai Medical Center, Los Angeles
EXoPERT EMERALD Clinical Study
招募中觀察性研究歡迎健康志工
- City of Hope Duarte Cancer Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- Cedars-Sinai Medical Center, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
招募中1 期
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- UCLA Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Cedars-Sinai Medical Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
招募中
- Cedars-Sinai Medical Center, Los Angeles
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
招募中1/2 期
- Cedars Sinai Medical Center, Los Angeles
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
招募中1 期
- Keck School of Medicine of USC, Los Angeles
- UCLA, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
招募中1/2 期
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
其他城市的 胰臟癌 試驗
- Houston, TX61 項研究
- New York City, NY60 項研究
- Boston, MA43 項研究
- Nashville, TN39 項研究
- St. Louis, MO33 項研究
- Arlington, VA33 項研究
- Baltimore, MD31 項研究
- San Antonio, TX31 項研究
- Philadelphia, PA26 項研究
- Tampa, FL26 項研究
- Durham, NC24 項研究
- San Diego, CA24 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）74 項研究
- 乳癌73 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
- 三陰性乳癌27 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。